vvn001
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
1
Phase 4
0
Earliest trial started Nov 1, 2020 (NCT04556838)
Timeline
Indications
Studied for
Mechanism of action
ITGAL inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06360133 | Phase 3 | Apr 1, 2024 | Fudan University, VivaVision Biotech, Inc |
| NCT04556838 | Phase 2 | Nov 1, 2020 | VivaVision Biotech, Inc |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| VivaVision Biotech, Inc | For profit | 2 | 2 | 2 | 2020 |
| Fudan University | Academic/Hospital | 1 | 0 | 1 | 2024 |
2 organizations
Page 1 / 1